Timber pharmaceuticals receives positive opinion on orphan designation from european medicines agency for tmb-001 for treatment of autosomal recessive congenital ichthyosis

European commission expected to issue its decision on orphan designation in approximately 30 days
TMBR Ratings Summary
TMBR Quant Ranking